Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of OMS302 during cataract or refractive lens replacement surgery
NL-OMON37657Phase 3Active, not recruiting
- Sponsor
- Omeros Corporation
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cataract comparing OMS302 irrigation solution with Placebo irrigation solution (2 arms). Primary endpoints: Change in pupil diameter over time and Early postoperative pain. Started Aug 2012; status: active, not recruiting.
02
Drugs
phenylephrine + ketorolac
03
Conditions
cataract
Beyond the preview
Go deeper on NL-OMON37657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37657.